156 related articles for article (PubMed ID: 24791641)
1. Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis.
Rivard JD; Temple WJ; McConnell YJ; Sultan H; Mack LA
Am J Surg; 2014 May; 207(5):760-4; discussion 764-5. PubMed ID: 24791641
[TBL] [Abstract][Full Text] [Related]
2. What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative.
Lee RM; Zaidi MY; Gamboa AC; Speegle S; Kimbrough CW; Cloyd JM; Leiting JL; Grotz TE; Lee AJ; Fournier KF; Powers BD; Dineen SP; Baumgartner J; Veerapong J; Clarke CN; Sussman JJ; Patel S; Hendrix RJ; Lambert LA; Vande Walle KA; Abbott DE; LaRocca CJ; Raoof M; Fackche N; Johnston FM; Staley CA; Maithel SK; Russell MC
Clin Colorectal Cancer; 2020 Mar; 19(1):e1-e7. PubMed ID: 31974019
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement.
de Bree E; Koops W; Kröger R; van Ruth S; Witkamp AJ; Zoetmulder FA
J Surg Oncol; 2004 May; 86(2):64-73. PubMed ID: 15112247
[TBL] [Abstract][Full Text] [Related]
4. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
de Bree E; Koops W; Kröger R; van Ruth S; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2006 Feb; 32(1):65-71. PubMed ID: 16290055
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.
Koh JL; Yan TD; Glenn D; Morris DL
Ann Surg Oncol; 2009 Feb; 16(2):327-33. PubMed ID: 19050972
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in peritoneal carcinomatosis.
Chang-Yun L; Yonemura Y; Ishibashi H; Sako S; Tsukiyama G; Kitai T; Matsuki N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2060-4. PubMed ID: 22202284
[TBL] [Abstract][Full Text] [Related]
7. Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery.
Mohkam K; Passot G; Cotte E; Bakrin N; Gilly FN; Ledochowski S; Bernard L; Valette PJ; Glehen O; Rousset P
Ann Surg Oncol; 2016 Apr; 23(4):1261-70. PubMed ID: 26628435
[TBL] [Abstract][Full Text] [Related]
8. Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
Suzuki C; Wallgren H; Abraham-Nordling M; Palmer G
Clin Radiol; 2018 Aug; 73(8):756.e11-756.e16. PubMed ID: 29678273
[TBL] [Abstract][Full Text] [Related]
9. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study.
Esquivel J; Chua TC; Stojadinovic A; Melero JT; Levine EA; Gutman M; Howard R; Piso P; Nissan A; Gomez-Portilla A; Gonzalez-Bayon L; Gonzalez-Moreno S; Shen P; Stewart JH; Sugarbaker PH; Barone RM; Hoefer R; Morris DL; Sardi A; Sticca RP
J Surg Oncol; 2010 Nov; 102(6):565-70. PubMed ID: 20976729
[TBL] [Abstract][Full Text] [Related]
10. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
[TBL] [Abstract][Full Text] [Related]
11. Preoperative assessment of peritoneal carcinomatosis of colorectal origin.
Dohan A; Hobeika C; Najah H; Pocard M; Rousset P; Eveno C
J Visc Surg; 2018 Sep; 155(4):293-303. PubMed ID: 29602696
[TBL] [Abstract][Full Text] [Related]
12. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.
Winer J; Zenati M; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2014 May; 21(5):1456-62. PubMed ID: 24201745
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of PET/CT in peritoneal carcinomatosis from colorectal cancer.
Bamba Y; Itabashi M; Kameoka S
Hepatogastroenterology; 2012; 59(117):1408-11. PubMed ID: 22094993
[TBL] [Abstract][Full Text] [Related]
14. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
15. Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma.
Elias D; Benizri E; Vernerey D; Eldweny H; Dipietrantonio D; Pocard M
Gastroenterol Clin Biol; 2005 Oct; 29(10):1010-3. PubMed ID: 16435508
[TBL] [Abstract][Full Text] [Related]
16. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients.
Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2013 Dec; 68(6):551-8. PubMed ID: 24193287
[TBL] [Abstract][Full Text] [Related]
17. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
18. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Yan TD; Haveric N; Carmignani CP; Chang D; Sugarbaker PH
Cancer; 2005 Feb; 103(4):839-49. PubMed ID: 15637690
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
[TBL] [Abstract][Full Text] [Related]
20. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
